A Study to Investigate Safety and Tolerability of SH3809 Tablet in Patients With Advanced Solid Tumors

NCT04843033 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: SH3809 tablet

Sponsor

Nanjing Sanhome Pharmaceutical, Co., Ltd.